Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

OneMedNet (ONMD) Shares Issued (2023 - 2025)

OneMedNet has reported Shares Issued over the past 2 years, most recently at $800000.0 for Q4 2025.

  • Quarterly Shares Issued changed N/A to $800000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.5 million for FY2025, 60.18% down from the prior year.
  • Shares Issued was $800000.0 for Q4 2025 at OneMedNet, up from $500000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $17.5 million in Q4 2023 and troughed at $500000.0 in Q3 2025.